Development and validation of a questionnaire to measure medication literacy in patients receiving oral anticancer drugs

Development and validation of a questionnaire to measure medication literacy in patients receiving oral anticancer drugs - AMIKO

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034341

Enrollment

300

Registered

2024-06-03

Start date

2024-06-03

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with oral anticancer drugs, regardless of the exact type of cancer C00-C97 D45 D46 D47 D48 E24.1

Interventions

Group 1: Patients receiving oral anticancer therapy complete a one-time survey that includes a medication literacy questionnaire and other questionnaires on quality of life (EQ-5D-5L), health literacy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - ICD-10 C diagnosis - Oral anticancer therapy - Medication self-administration - Written consent to participate in the study - Treatment in an oncological practice

Exclusion criteria

Exclusion criteria: - Off-label therapy - Lack of German language skills - Other conditions or diseases that impair understanding of the questionnaire (e.g. dementia)

Design outcomes

Primary

Measure	Time frame
Development of a questionnaire to measure medication literacy in patients receiving oral anticancer drugs	—

Secondary

Measure	Time frame
Evaluation of the validity of the questionnaire using univariate and multivariate regression analyses	—

Countries

Germany

Contacts

Public ContactUlrich Jaehde

Pharmazeutisches Institut

u.jaehde@uni-bonn.de+49 228 73 5252

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026